Overview

Gender

male

Daniel is President of the University of Texas Southwestern Medical Center in Dallas and holds the Philip O’Bryan Montgomery, Jr M.D. Distinguished Presidential Chair in Academic Administration, and the Doris and Bryan Wildenthal Distinguished Chair in Medical Science.

Daniel is a member of the Institute of Medicine of the US National Academy of Sciences, the Council of Teaching Hospitals of the Association of Academic Medical Centers, and the Board of the Southwestern Medical Foundation. He is also a Director of Antibe Therapeutics, Inc.

Previously, he served as Co-Chairman of the Board and Scientific Co-Founder of the GI Company, Inc, served as the Chief Academic Officer of Partners HealthCare System and was formerly Mallinckrodt Professor of Medicine and Chief of Gastroenterology at Massachusetts General Hospital and Harvard Medical School. Daniel is a world-renowned researcher who has advanced knowledge of underlying mechanisms of disease and new therapies for gastrointestinal disorders. He is also an international authority on trefoil proteins and innate immunity.

Daniel has published and patented widely in his field, He is past editor-in-chief of Gastroenterology, the leading journal in the field, and is immediate Past President of the American Gastroenterological Association.